Midostaurin for patients with acute myeloid leukemia and FLT3 mutations.
Midostaurin for patients with acute myeloid leukemia and FLT3 mutations.
Clin Adv Hematol Oncol. 2019 Jun;17(6):323-325
Authors: Levis MJ
PMID: 31437132 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research